Have you evaluated the performance of Thermo Fisher Scientific's (TMO) international operations during the quarter that concluded in June 2026? Considering the extensive worldwide presence of this maker of scientific instrument and laboratory supplies, analyzing the patterns in international revenues is crucial for understanding its financial resilience and potential for growth.
In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For investors, the key is to grasp how reliant a company is on overseas markets, as this provides insights into the durability of its earnings, its ability to exploit different economic cycles, and its overall growth capabilities.
International market involvement serves as insurance against economic downturns at home and enables engagement with economies that are growing more quickly. Still, this move toward diversification is not without its challenges, as it involves navigating through the fluctuations of currencies, geopolitical threats, and the distinctive nature of various markets.
Our review of TMO's last quarterly performance uncovered some notable trends in the revenue contributions from its international markets, which are commonly analyzed and tracked by Wall Street experts.
The recent quarter saw the company's total revenue reaching $11.99 billion, marking an improvement of 10.5% from the prior-year quarter. Next, we'll examine the breakdown of TMO's revenue from abroad to comprehend the significance of its international presence.
Unveiling Trends in TMO's International Revenues
Other regions generated $430 million in revenues for the company in the last quarter, constituting 3.6% of the total. This represented a surprise of +16.76% compared to the $368.27 million projected by Wall Street analysts. Comparatively, in the previous quarter, Other regions accounted for $372 million (3.4%), and in the year-ago quarter, it contributed $383 million (3.5%) to the total revenue.
Of the total revenue, $2.1 billion came from Asia-Pacific during the last fiscal quarter, accounting for 17.5%. This represented a surprise of -1.87% as analysts had expected the region to contribute $2.14 billion to the total revenue. In comparison, the region contributed $1.97 billion, or 17.9%, and $1.92 billion, or 17.7%, to total revenue in the previous and year-ago quarters, respectively.
During the quarter, Europe contributed $3.31 billion in revenue, making up 27.6% of the total revenue. When compared to the consensus estimate of $3 billion, this meant a surprise of +10.46%. Looking back, Europe contributed $2.96 billion, or 26.9%, in the previous quarter, and $2.83 billion, or 26.1%, in the same quarter of the previous year.
Revenue Forecasts for the International Markets
Wall Street analysts expect Thermo Fisher to report $11.91 billion in total revenue for the current fiscal quarter, indicating an increase of 7.1% from the year-ago quarter. Other regions, Asia-Pacific and Europe are expected to contribute 3.2% (translating to $376.78 million), 18.4% ($2.19 billion), and 25.7% ($3.07 billion) to the total revenue, respectively.
For the full year, the company is expected to generate $47.8 billion in total revenue, up 7.3% from the previous year. Revenues from Other regions, Asia-Pacific and Europe are expected to constitute 3.1% ($1.5 billion), 18.2% ($8.71 billion) and 25.5% ($12.17 billion) of the total, respectively.
The Bottom Line
The dependency of Thermo Fisher on global markets for its revenues presents a mix of potential gains and hazards. Thus, monitoring the trends in its overseas revenues can be a key indicator for predicting the firm's future performance.
In an era of growing international interdependencies and escalating geopolitical disputes, Wall Street analysts are vigilant in tracking these trends for businesses with a global reach, in order to refine their predictions of earnings. It should be noted, however, that a multitude of other elements, such as a company's domestic position, also play a significant role in shaping the earnings forecasts.
At Zacks, a company's changing earnings outlook is given considerable attention due to its proven, strong influence on a stock's price performance in the near term. The connection here is straightforward and positive: when earnings estimates are revised upward, the stock price generally follows suit, increasing as well.
The Zacks Rank, our proprietary stock rating tool, comes with an externally validated impressive track record. It effectively utilizes shifts in earnings projections to act as a dependable barometer for forecasting short-term stock price trends.
A Look at Thermo Fisher Scientific's Recent Stock Price Performance
Over the past month, the stock has gained 9.7% versus the Zacks S&P 500 composite's 0.2% increase. The Zacks Medical sector, of which Thermo Fisher is a part, has risen 0.7% over the same period. The company's shares have increased 23.5% over the past three months compared to the S&P 500's 4.2% increase. Over the same period, the sector has risen 7.9%
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.